CDH5 and neoplasm: While treatment had no effect on cancer cells, PFKFB3 inhibition did result in a significant reduction in lung metastasis (p < 0.05) and was accompanied by tumor vessel normalization, demonstrated by increased vessel lumen size, increased perfusion, a decrease in hypoxia markers, an upregulation of VE-cadherin and an enhanced recruitment of pericytes.